Log In or Register to Join The Conversation!

This topic is empty.

  • Author
    Posts
    • #22715

      Anticipation is growing as Roche/Genentech’s treatment risdiplam, the first oral medication to treat SMA, is under FDA review.

      Also, SMA News Today’s multimedia associate, Price Wooldridge, discusses how the lack of SMA protein may also directly contribute to SMA.

      Are you interested in learning more about spinal muscular atrophy? If so, please visit smanewstoday.com/

      What are your thoughts on this news? Let us know about it in the comment section below.
Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2020 All rights reserved.